GUDULA ZOE GLOVA: Open Payments
NPI 1346604279 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 17 payments from 8 companies in 2025. Trend: 2023 $59 · 2024 $177 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $170 |
| Sumitomo Pharma America, Inc. | 6 | $153 |
| Medtronic, Inc. | 3 | $69 |
| ConvaTec Inc. | 1 | $59 |
| ABBVIE INC. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $23 |
| Procept Biorobotics Corporation | 1 | $19 |
| Endo USA, Inc. | 1 | $17 |
Products named: GEMTESA, RYBREVANT, GENTLECATH GLIDE, ERLEADA, ALTAVIVA, INTERSTIM, BOTOX, XYOSTED.
Industry payments across PA — which companies pay providers there.
